Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
Françoise Denoyelle(Hôpital Necker-Enfants Malades), Éréa-Noël Garabédian(Inserm), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), O Enjolras(Hôpital Armand-Trousseau), Robert Harris(Sorbonne Université), Gilles Roger(Inserm)
Cited by 235
Related Papers
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|558
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
|Human Mutation|2008|429
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol
|PEDIATRICS|2015|113
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110